OR30-5 Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer

por Richer, Jennifer, Spoelstra, Nicole, Williams, Michelle, Crump, Lyndsey
Publicado 2022

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

por Cochrane, Dawn R., Howe, Erin N., Spoelstra, Nicole S., Richer, Jennifer K.
Publicado 2010

Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes

por Niemeyer, Brian F., Parrish, Janet K., Spoelstra, Nicole S., Joyal, Teresa, Richer, Jennifer K., Jedlicka, Paul
Publicado 2015

Secreted indicators of androgen receptor activity in breast cancer pre-clinical models

por Hanamura, Toru, Christenson, Jessica L., O’Neill, Kathleen I., Rosas, Emmanuel, Spoelstra, Nicole S., Williams, Michelle M., Richer, Jennifer K.
Publicado 2021

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

por Cittelly, Diana M, Das, Partha M, Spoelstra, Nicole S, Edgerton, Susan M, Richer, Jennifer K, Thor, Ann D, Jones, Frank E
Publicado 2010

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer

por Li, Zheqi, Spoelstra, Nicole S., Sikora, Matthew J., Sams, Sharon B., Elias, Anthony, Richer, Jennifer K., Lee, Adrian V., Oesterreich, Steffi
Publicado 2022

A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer

por Lazova, Rossitza, LaBerge, Greggory S., Duvall, Eric, Spoelstra, Nicole, Klump, Vincent, Sznol, Mario, Cooper, Dennis, Spritz, Richard A., Chang, Joseph T., Pawelek, John M.
Publicado 2013

MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer

por Williams, Michelle M., Christenson, Jessica L., O’Neill, Kathleen I., Hafeez, Sabrina A., Ihle, Claire L., Spoelstra, Nicole S., Slansky, Jill E., Richer, Jennifer K.
Publicado 2021

NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer

por O’Neill, Kathleen I., Kuo, Li-Wei, Williams, Michelle M., Lind, Hanne, Crump, Lyndsey S., Hammond, Nia G., Spoelstra, Nicole S., Caino, M. Cecilia, Richer, Jennifer K.
Publicado 2022

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer

por Fernández, Natalia B., Sosa, Sofía M., Roberts, Justin T., Recouvreux, María S., Rocha-Viegas, Luciana, Christenson, Jessica L., Spoelstra, Nicole S., Couto, Facundo L., Raimondi, Ana R., Richer, Jennifer K., Rubinstein, Natalia
Publicado 2023

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

por Cochrane, Dawn R, Bernales, Sebastián, Jacobsen, Britta M, Cittelly, Diana M, Howe, Erin N, D’Amato, Nicholas C, Spoelstra, Nicole S, Edgerton, Susan M, Jean, Annie, Guerrero, Javier, Gómez, Francisco, Medicherla, Satyanarayana, Alfaro, Iván E, McCullagh, Emma, Jedlicka, Paul, Torkko, Kathleen C, Thor, Ann D, Elias, Anthony D, Protter, Andrew A, Richer, Jennifer K
Publicado 2014

Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer

por Elias, Anthony D., Spoelstra, Nicole S., Staley, Alyse W., Sams, Sharon, Crump, Lyndsey S., Vidal, Gregory A., Borges, Virginia F., Kabos, Peter, Diamond, Jennifer R., Shagisultanova, Elena, Afghahi, Anosheh, Mayordomo, Jose, McSpadden, Tessa, Crawford, Gloria, D’Alessandro, Angelo, Zolman, Kathryn L., van Bokhoven, Adrie, Zhuang, Yonghua, Gallagher, Rosa I., Wulfkuhle, Julia D., Petricoin III, Emanuel F., Gao, Dexiang, Richer, Jennifer K.
Publicado 2023